PEAQX tetrasodium hydrate

CAS : 459836-30-7

Ref. 3D-JTA83630

Informations sur le produit

• Nom: PEAQX tetrasodium hydrate
• CAS: 459836-30-7

Description

PEAQX tetrasodium hydrate is a new drug for the treatment of ovarian hyperstimulation syndrome (OHSS) and endometriosis. It has been shown to be effective in reducing the symptoms of both conditions. PEAQX tetrasodium hydrate is administered by intramuscular injection. The drug acts as a constant, rather than a bolus, which helps to reduce the number of injections required and improves patient compliance. It has been shown that PEAQX tetrasodium hydrate can also be used for insemination in pediatric patients when combined with ovulation induction drugs.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 542.14 g/mol
• Formule: C₁₇H₁₃BrN₃Na₄O₅P·xH₂O
• Degré de pureté: Min. 95%